Skip to main content
Top
Published in: European Journal of Nutrition 3/2017

01-04-2017 | Original Contribution

Effects of vitamin D supplementation on endothelial function: a systematic review and meta-analysis of randomised clinical trials

Authors: Azizah Mat Hussin, Ammar W. Ashor, Inez Schoenmakers, Tom Hill, John C. Mathers, Mario Siervo

Published in: European Journal of Nutrition | Issue 3/2017

Login to get access

Abstract

Background

In addition to regulating calcium homoeostasis and bone health, vitamin D influences vascular and metabolic processes including endothelial function (EF) and insulin signalling. This systematic review and meta-analysis of randomised clinical trials (RCTs) were conducted to investigate the effect of vitamin D supplementation on EF and to examine whether the effect size was modified by health status, study duration, dose, route of vitamin D administration, vitamin D status (baseline and post-intervention), body mass index (BMI), age and type of vitamin D.

Methods

We searched the Medline, Embase, Cochrane Library and Scopus databases from inception until March 2015 for studies meeting the following criteria: (1) RCT with adult participants, (2) vitamin D administration alone, (3) studies that quantified EF using commonly applied methods including ultrasound, plethysmography, applanation tonometry and laser Doppler.

Results

Sixteen articles reporting data for 1177 participants were included. Study duration ranged from 4 to 52 weeks. The effect of vitamin D on EF was not significant (SMD: 0.08, 95 % CI −0.06, 0.22, p = 0.28). Subgroup analysis showed a significant improvement of EF in diabetic subjects (SMD: 0.31, 95 % CI 0.05, 0.57, p = 0.02). A non-significant trend was found for diastolic blood pressure (β = 0.02; p = 0.07) and BMI (β = 0.05; p = 0.06).

Conclusions

Vitamin D supplementation did not improve EF. The significant effect of vitamin D in diabetics and a tendency for an association with BMI may indicate a role of excess adiposity and insulin resistance in modulating the effects of vitamin D on vascular function. This remains to be tested in future studies.
Appendix
Available only for authorised users
Literature
1.
go back to reference Dahlof B (2010) Cardiovascular disease risk factors: epidemiology and risk assessment. Am J Cardiol 105:3a–9aCrossRef Dahlof B (2010) Cardiovascular disease risk factors: epidemiology and risk assessment. Am J Cardiol 105:3a–9aCrossRef
2.
go back to reference Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352:1685–1695CrossRef Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352:1685–1695CrossRef
3.
go back to reference Higashi Y et al (2009) Endothelial function and oxidative stress in cardiovascular diseases. Circ J 73:411–418CrossRef Higashi Y et al (2009) Endothelial function and oxidative stress in cardiovascular diseases. Circ J 73:411–418CrossRef
4.
go back to reference Endemann DH, Schiffrin EL (2004) Endothelial dysfunction. J Am Soc Nephrol 15:1983–1992CrossRef Endemann DH, Schiffrin EL (2004) Endothelial dysfunction. J Am Soc Nephrol 15:1983–1992CrossRef
5.
6.
go back to reference Brandenburg VM et al (2012) The role of vitamin D in cardiovascular disease: from present evidence to future perspectives. Atherosclerosis 225:253–263CrossRef Brandenburg VM et al (2012) The role of vitamin D in cardiovascular disease: from present evidence to future perspectives. Atherosclerosis 225:253–263CrossRef
7.
go back to reference Dalan R et al (2014) Vitamin D and the endothelium: basic, translational and clinical research updates. IJC Metab Endocr 4:4–17CrossRef Dalan R et al (2014) Vitamin D and the endothelium: basic, translational and clinical research updates. IJC Metab Endocr 4:4–17CrossRef
8.
go back to reference Andrukhova O et al (2014) Vitamin D is a regulator of endothelial nitric oxide synthase and arterial stiffness in mice. Mol Endocrinol 28:53–64CrossRef Andrukhova O et al (2014) Vitamin D is a regulator of endothelial nitric oxide synthase and arterial stiffness in mice. Mol Endocrinol 28:53–64CrossRef
9.
go back to reference Liu S et al (2005) Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care 28:2926–2932CrossRef Liu S et al (2005) Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care 28:2926–2932CrossRef
10.
go back to reference Pittas AG et al (2006) Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 29:650–656CrossRef Pittas AG et al (2006) Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 29:650–656CrossRef
11.
go back to reference Knekt P et al (2008) Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology (Cambridge, Mass) 19:666–671CrossRef Knekt P et al (2008) Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology (Cambridge, Mass) 19:666–671CrossRef
12.
go back to reference Bajaj A et al (2014) Circulating vitamin D, supplement use, and cardiovascular disease risk: the MrOS sleep study. J Clin Endocrinol Metab 99:3256–3262CrossRef Bajaj A et al (2014) Circulating vitamin D, supplement use, and cardiovascular disease risk: the MrOS sleep study. J Clin Endocrinol Metab 99:3256–3262CrossRef
13.
go back to reference Sollid ST et al (2014) No effect of high-dose vitamin D supplementation on glycemic status or cardiovascular risk factors in subjects with prediabetes. Diabetes Care 37(8):2123–2131 Sollid ST et al (2014) No effect of high-dose vitamin D supplementation on glycemic status or cardiovascular risk factors in subjects with prediabetes. Diabetes Care 37(8):2123–2131
14.
go back to reference Pittas AG et al (2010) Systematic review: vitamin D and cardiometabolic outcomes. Ann Intern Med 152:307–314CrossRef Pittas AG et al (2010) Systematic review: vitamin D and cardiometabolic outcomes. Ann Intern Med 152:307–314CrossRef
15.
go back to reference Breslavsky A et al (2013) Effect of high doses of vitamin D on arterial properties, adiponectin, leptin and glucose homeostasis in type 2 diabetic patients. Clin Nutr 32:970–975CrossRef Breslavsky A et al (2013) Effect of high doses of vitamin D on arterial properties, adiponectin, leptin and glucose homeostasis in type 2 diabetic patients. Clin Nutr 32:970–975CrossRef
16.
go back to reference Harris RA et al (2011) Vitamin D3 supplementation for 16 weeks improves flow-mediated dilation in overweight African-American adults. Am J Hypertens 24:557–562CrossRef Harris RA et al (2011) Vitamin D3 supplementation for 16 weeks improves flow-mediated dilation in overweight African-American adults. Am J Hypertens 24:557–562CrossRef
17.
go back to reference Sugden JA et al (2008) Vitamin D improves endothelial function in patients with type 2 diabetes mellitus and low vitamin D levels. Diabet Med J Br Diabet Assoc 25:320–325CrossRef Sugden JA et al (2008) Vitamin D improves endothelial function in patients with type 2 diabetes mellitus and low vitamin D levels. Diabet Med J Br Diabet Assoc 25:320–325CrossRef
18.
go back to reference Gepner AD et al (2012) A prospective randomized controlled trial of the effects of vitamin D supplementation on cardiovascular disease risk. PLoS one 7:e36617 (Electronic Resource) CrossRef Gepner AD et al (2012) A prospective randomized controlled trial of the effects of vitamin D supplementation on cardiovascular disease risk. PLoS one 7:e36617 (Electronic Resource) CrossRef
19.
go back to reference Hewitt NA et al (2013) Effects of cholecalciferol on functional, biochemical, vascular, and quality of life outcomes in hemodialysis patients. Clin J Am Soc Nephrol CJASN 8:1143–1149CrossRef Hewitt NA et al (2013) Effects of cholecalciferol on functional, biochemical, vascular, and quality of life outcomes in hemodialysis patients. Clin J Am Soc Nephrol CJASN 8:1143–1149CrossRef
20.
go back to reference Larsen T et al (2012) Effect of cholecalciferol supplementation during winter months in patients with hypertension: a randomized, placebo-controlled trial. Am J Hypertens 25:1215–1222CrossRef Larsen T et al (2012) Effect of cholecalciferol supplementation during winter months in patients with hypertension: a randomized, placebo-controlled trial. Am J Hypertens 25:1215–1222CrossRef
21.
go back to reference Longenecker CT et al (2012) Vitamin D supplementation and endothelial function in vitamin D deficient HIV-infected patients: a randomized placebo-controlled trial. Antivir Ther 17:613–621CrossRef Longenecker CT et al (2012) Vitamin D supplementation and endothelial function in vitamin D deficient HIV-infected patients: a randomized placebo-controlled trial. Antivir Ther 17:613–621CrossRef
22.
go back to reference Marckmann P et al (2012) Randomized controlled trial of cholecalciferol supplementation in chronic kidney disease patients with hypovitaminosis D. Nephrol Dial Transplant 27:3523–3531CrossRef Marckmann P et al (2012) Randomized controlled trial of cholecalciferol supplementation in chronic kidney disease patients with hypovitaminosis D. Nephrol Dial Transplant 27:3523–3531CrossRef
23.
go back to reference Sokol SI et al (2012) The effects of vitamin D repletion on endothelial function and inflammation in patients with coronary artery disease. Vasc Med (United Kingdom) 17:394–404CrossRef Sokol SI et al (2012) The effects of vitamin D repletion on endothelial function and inflammation in patients with coronary artery disease. Vasc Med (United Kingdom) 17:394–404CrossRef
24.
go back to reference Stricker H et al (2012) Effect of a single, oral, high-dose vitamin D supplementation on endothelial function in patients with peripheral arterial disease: a randomised controlled pilot study. Eur J Vasc Endovasc Surg 44:307–312CrossRef Stricker H et al (2012) Effect of a single, oral, high-dose vitamin D supplementation on endothelial function in patients with peripheral arterial disease: a randomised controlled pilot study. Eur J Vasc Endovasc Surg 44:307–312CrossRef
25.
go back to reference Witham MD et al (2010) The effect of different doses of vitamin D(3) on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial. Diabetologia 53:2112–2119CrossRef Witham MD et al (2010) The effect of different doses of vitamin D(3) on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial. Diabetologia 53:2112–2119CrossRef
26.
go back to reference Witham MD et al (2012) The effect of vitamin D replacement on markers of vascular health in stroke patients—a randomised controlled trial. Nutr Metab Cardiovasc Dis 22:864–870CrossRef Witham MD et al (2012) The effect of vitamin D replacement on markers of vascular health in stroke patients—a randomised controlled trial. Nutr Metab Cardiovasc Dis 22:864–870CrossRef
27.
go back to reference Beveridge LA, Witham MD (2013) Vitamin D and the cardiovascular system. Osteoporos Int 24:2167–2180CrossRef Beveridge LA, Witham MD (2013) Vitamin D and the cardiovascular system. Osteoporos Int 24:2167–2180CrossRef
28.
go back to reference Witham MD et al (2013) Effects of vitamin D supplementation on markers of vascular function after myocardial infarction–a randomised controlled trial. Int J Cardiol 167:745–749CrossRef Witham MD et al (2013) Effects of vitamin D supplementation on markers of vascular function after myocardial infarction–a randomised controlled trial. Int J Cardiol 167:745–749CrossRef
29.
go back to reference Witham MD et al (2013) Cholecalciferol treatment to reduce blood pressure in older patients with isolated systolic hypertension: the VitDISH randomized controlled trial. JAMA Intern Med 173:1672–1679 Witham MD et al (2013) Cholecalciferol treatment to reduce blood pressure in older patients with isolated systolic hypertension: the VitDISH randomized controlled trial. JAMA Intern Med 173:1672–1679
30.
go back to reference Yiu YF et al (2013) Randomized controlled trial of vitamin D supplement on endothelial function in patients with type 2 diabetes. Atherosclerosis 227:140–146CrossRef Yiu YF et al (2013) Randomized controlled trial of vitamin D supplement on endothelial function in patients with type 2 diabetes. Atherosclerosis 227:140–146CrossRef
31.
go back to reference Stojanović M, Radenković M (2015) Vitamin D versus placebo in improvement of endothelial dysfunction: a meta-analysis of randomized clinical trials. Cardiovasc Ther 33:145–154CrossRef Stojanović M, Radenković M (2015) Vitamin D versus placebo in improvement of endothelial dysfunction: a meta-analysis of randomized clinical trials. Cardiovasc Ther 33:145–154CrossRef
32.
go back to reference Siervo M et al (2011) Measurement of in vivo nitric oxide synthesis in humans using stable isotopic methods: a systematic review. Free Radic Biol Med 51:795–804CrossRef Siervo M et al (2011) Measurement of in vivo nitric oxide synthesis in humans using stable isotopic methods: a systematic review. Free Radic Biol Med 51:795–804CrossRef
33.
go back to reference Higgins JPT, Green S (2008) Guide to the contents of a Cochrane protocol and review. In: Higgins JP, Green S (eds) Cochrane handbook for systematic reviews of interventions. John Wiley & Sons, Ltd, Chichester, UK, pp 51–79 Higgins JPT, Green S (2008) Guide to the contents of a Cochrane protocol and review. In: Higgins JP, Green S (eds) Cochrane handbook for systematic reviews of interventions. John Wiley & Sons, Ltd, Chichester, UK, pp 51–79
34.
go back to reference Liberati A, et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700 Liberati A, et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700
35.
go back to reference Crowther M et al (2010) Systematic review and meta-analysis methodology. Blood 116:3140–3146CrossRef Crowther M et al (2010) Systematic review and meta-analysis methodology. Blood 116:3140–3146CrossRef
36.
go back to reference Ross AC, Taylor CL, Yaktine AL, Del Valle HB (eds) (2011) Dietary reference intakes for calcium and vitamin D. The National Academies Press, Washington, DC Ross AC, Taylor CL, Yaktine AL, Del Valle HB (eds) (2011) Dietary reference intakes for calcium and vitamin D. The National Academies Press, Washington, DC
37.
go back to reference Cummings P (2011) Arguments for and against standardized mean differences (effect sizes). Arch Pediatr Adolesc Med 165:592–596CrossRef Cummings P (2011) Arguments for and against standardized mean differences (effect sizes). Arch Pediatr Adolesc Med 165:592–596CrossRef
38.
go back to reference Higgins JPT, et al (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560 Higgins JPT, et al (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560
39.
go back to reference Egger M et al (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ (Clin Res Ed) 315:629–634CrossRef Egger M et al (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ (Clin Res Ed) 315:629–634CrossRef
40.
go back to reference Witham MD et al (2013) Effect of short-term vitamin D supplementation on markers of vascular health in South Asian women living in the UK—a randomised controlled trial. Atherosclerosis 230:293–299CrossRef Witham MD et al (2013) Effect of short-term vitamin D supplementation on markers of vascular health in South Asian women living in the UK—a randomised controlled trial. Atherosclerosis 230:293–299CrossRef
41.
go back to reference Harris RA, et al (2011) Vitamin D improves flow-mediated dilation in African American adults. FASEB J 24(5):557–562 Harris RA, et al (2011) Vitamin D improves flow-mediated dilation in African American adults. FASEB J 24(5):557–562
42.
go back to reference Wu SH et al (2010) Effects of vitamin D supplementation on blood pressure. South Med J 103:729–737CrossRef Wu SH et al (2010) Effects of vitamin D supplementation on blood pressure. South Med J 103:729–737CrossRef
43.
go back to reference Kassi E et al (2013) Role of vitamin D in atherosclerosis. Circulation 128:2517–2531CrossRef Kassi E et al (2013) Role of vitamin D in atherosclerosis. Circulation 128:2517–2531CrossRef
44.
go back to reference Somjen D et al (2000) Vitamin D analogs modulate the action of gonadal steroids in human vascular cells in vitro. Am J Hypertens 13:396–403CrossRef Somjen D et al (2000) Vitamin D analogs modulate the action of gonadal steroids in human vascular cells in vitro. Am J Hypertens 13:396–403CrossRef
45.
go back to reference Molinari C et al (2011) 1alpha, 25-dihydroxycholecalciferol induces nitric oxide production in cultured endothelial cells. Cell Physiol Biochem 27:661–668CrossRef Molinari C et al (2011) 1alpha, 25-dihydroxycholecalciferol induces nitric oxide production in cultured endothelial cells. Cell Physiol Biochem 27:661–668CrossRef
46.
go back to reference Aihara K et al (2006) Vitamin D-vitamin D receptor system regulates antithrombogenicity in vivo. Clin Calcium 16:1173–1179 Aihara K et al (2006) Vitamin D-vitamin D receptor system regulates antithrombogenicity in vivo. Clin Calcium 16:1173–1179
47.
go back to reference Almirall J et al (2010) Association of low serum 25-hydroxyvitamin D levels and high arterial blood pressure in the elderly. Nephrol Dial Transplant 25:503–509CrossRef Almirall J et al (2010) Association of low serum 25-hydroxyvitamin D levels and high arterial blood pressure in the elderly. Nephrol Dial Transplant 25:503–509CrossRef
48.
go back to reference Bednarski R et al (2007) Role of vitamin D3 in arterial blood pressure control. Polski Merkuriusz Lekarski 23:307–310 Bednarski R et al (2007) Role of vitamin D3 in arterial blood pressure control. Polski Merkuriusz Lekarski 23:307–310
49.
go back to reference Chai W et al (2013) Effects of calcium and vitamin D supplementation on blood pressure and serumlipids and carotenoids: a randomized, double-blind, placebo-controlled, clinical trial. Ann Epidemiol 23:564–570CrossRef Chai W et al (2013) Effects of calcium and vitamin D supplementation on blood pressure and serumlipids and carotenoids: a randomized, double-blind, placebo-controlled, clinical trial. Ann Epidemiol 23:564–570CrossRef
50.
go back to reference Cosenso-Martin LN, Vilela-Martin JF (2011) Is there an association between vitamin D and hypertension? Recent Pat Cardiovasc Drug Discov 6:140–147CrossRef Cosenso-Martin LN, Vilela-Martin JF (2011) Is there an association between vitamin D and hypertension? Recent Pat Cardiovasc Drug Discov 6:140–147CrossRef
51.
go back to reference Borissova AM et al (2003) The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract 57:258–261 Borissova AM et al (2003) The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract 57:258–261
52.
go back to reference Al Mheid I et al (2011) Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans. J Am Coll Cardiol 58:186–192CrossRef Al Mheid I et al (2011) Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans. J Am Coll Cardiol 58:186–192CrossRef
53.
go back to reference Nadir MA et al (2010) Vitamin D and cardiovascular prevention. Cardiovasc Ther 28:e5–e12CrossRef Nadir MA et al (2010) Vitamin D and cardiovascular prevention. Cardiovasc Ther 28:e5–e12CrossRef
54.
go back to reference Grandi NC et al (2010) Vitamin D and cardiovascular disease: systematic review and meta-analysis of prospective studies. Prev Med 51:228–233CrossRef Grandi NC et al (2010) Vitamin D and cardiovascular disease: systematic review and meta-analysis of prospective studies. Prev Med 51:228–233CrossRef
55.
go back to reference Song Y et al (2013) Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care 36:1422–1428CrossRef Song Y et al (2013) Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care 36:1422–1428CrossRef
56.
go back to reference Williams S et al (2009) Vitamin D and chronic kidney disease. Ethn Dis 19(4 Suppl 5):S5-8–11 Williams S et al (2009) Vitamin D and chronic kidney disease. Ethn Dis 19(4 Suppl 5):S5-8–11
57.
go back to reference Ruggiero M, Pacini S (2009) Chronic kidney disease and vitamin D: how much is adequate? Kidney Int 76:931–933CrossRef Ruggiero M, Pacini S (2009) Chronic kidney disease and vitamin D: how much is adequate? Kidney Int 76:931–933CrossRef
58.
go back to reference Pittas AG et al (2007) The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 92:2017–2029CrossRef Pittas AG et al (2007) The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 92:2017–2029CrossRef
59.
go back to reference Maestro B et al (2002) Transcriptional activation of the human insulin receptor gene by 1, 25-dihydroxyvitamin D3. Cell Biochem Funct 20:227–232CrossRef Maestro B et al (2002) Transcriptional activation of the human insulin receptor gene by 1, 25-dihydroxyvitamin D3. Cell Biochem Funct 20:227–232CrossRef
60.
go back to reference Maestro B et al (2000) Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr J 47:383–391CrossRef Maestro B et al (2000) Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr J 47:383–391CrossRef
61.
go back to reference Nagpal S et al (2005) Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 26:662–687CrossRef Nagpal S et al (2005) Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 26:662–687CrossRef
62.
go back to reference Siervo M et al (2011) Post-challenge hyperglycaemia, nitric oxide production and endothelial dysfunction: the putative role of asymmetric dimethylarginine (ADMA). Nutr Metab Cardiovasc Dis NMCD 21:1–10CrossRef Siervo M et al (2011) Post-challenge hyperglycaemia, nitric oxide production and endothelial dysfunction: the putative role of asymmetric dimethylarginine (ADMA). Nutr Metab Cardiovasc Dis NMCD 21:1–10CrossRef
63.
go back to reference Wortsman J et al (2000) Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72:690–693 Wortsman J et al (2000) Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72:690–693
64.
go back to reference Rodríguez-Rodríguez E et al (2009) Vitamin D in overweight/obese women and its relationship with dietetic and anthropometric variables. Obesity 17:778–782CrossRef Rodríguez-Rodríguez E et al (2009) Vitamin D in overweight/obese women and its relationship with dietetic and anthropometric variables. Obesity 17:778–782CrossRef
65.
go back to reference Vilarrasa N et al (2007) Low 25-hydroxyvitamin D concentrations in obese women: their clinical significance and relationship with anthropometric and body composition variables. J Endocrinol Invest 30:653–658CrossRef Vilarrasa N et al (2007) Low 25-hydroxyvitamin D concentrations in obese women: their clinical significance and relationship with anthropometric and body composition variables. J Endocrinol Invest 30:653–658CrossRef
66.
67.
go back to reference Tripkovic L et al (2012) Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. Am J Clin Nutr 95:1357–1364CrossRef Tripkovic L et al (2012) Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. Am J Clin Nutr 95:1357–1364CrossRef
68.
go back to reference Cashman KD et al (2014) Dietary vitamin D(2)–a potentially underestimated contributor to vitamin D nutritional status of adults? Br J Nutr 112:193–202CrossRef Cashman KD et al (2014) Dietary vitamin D(2)–a potentially underestimated contributor to vitamin D nutritional status of adults? Br J Nutr 112:193–202CrossRef
Metadata
Title
Effects of vitamin D supplementation on endothelial function: a systematic review and meta-analysis of randomised clinical trials
Authors
Azizah Mat Hussin
Ammar W. Ashor
Inez Schoenmakers
Tom Hill
John C. Mathers
Mario Siervo
Publication date
01-04-2017
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nutrition / Issue 3/2017
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-016-1159-3

Other articles of this Issue 3/2017

European Journal of Nutrition 3/2017 Go to the issue